Analyst Ratings for Apellis Pharmaceuticals (APLS)
APLS Rating Summary
APLS Price Target Summary
- Highest: $45.00 (TD Cowen)
- Lowest: $19.00 (Goldman Sachs)
- Average: $37.67
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$37.67 (-8.2%)
* Over Last 12-Mos
Rating Score: 2 / 10
Percentile Rank: 15%
Avg. $ Target:
$37.67 (-8.2%)
* Over Last 12-Mos
Rating Score: 2 / 10
Percentile Rank: 15%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/17/2026 | Wells Fargo | Derek Archila | Downgrade | Equal Weight (Overweight) |
41.00 (26.00) |
40.87 (41.03) |
0.39% | Details |
| 4/2/2026 | Roth/MKM | Adam Walsh | Downgrade | Neutral (Buy) |
41.00 (N/A) |
40.23 (41.03) |
1.99% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
